SF Journal of Pulmonology and Respiration Care
SFJPRC

Yupingfeng Prescription, a Complementary Strategy against Corona Virus Disease 2019 (COVID-19)?

Mini Review Volume 1 Issue 1
Li LC, Fang HM and Kan LD*
Corresponding Author: Kan LD

Abstract

The Corona virus Disease 2019 (COVID-19) has led to unprecedented health emergency over the world. Till May 2, 2020, over 240,000 people were died due to this serious viral prevalence. Unfortunately, few specific drugs have been developed so far. Yupingfeng prescription is a commonly used Chinese preparation to treat lung disease in China.

Article Information

Journal SF Journal of Pulmonology and Respiration Care
Article Type Mini Review
Volume 1
Issue 1